Beroni Group Ltd Overview
Pro stress-test →Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies.
Strategic Profile
Pro stress-test →The company operates through four segments: Cell Therapies; Developing New Anti-Cancer Drugs; E-commerce Platform for Pharmaceutical and Healthcare Products; and Detection & Diagnosis of Infectious Diseases. Beroni has operations in Australia, United States, China and Japan.
Competitive Landscape
Pro stress-test →Beroni competes in fragmented markets across diagnostics (vs. major IVD manufacturers like Abbott, Roche), cell therapy (vs. established biotech firms), and pharmaceutical e-commerce (vs. online pharmacy platforms). The company's diversification across uncorrelated markets reduces direct competition but limits scale advantages in any single segment.
Industry Context
Beroni Group Ltd operates in Biopharmaceuticals & Medical Diagnostics.
Key facts
Founded: N/A · Headquarters: Sydney, Australia · Employees: N/A · Revenue: N/A · Market cap: $180K (as of March 2026)